nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitric Oxide—CYP3A4—Fingolimod—multiple sclerosis	0.118	0.206	CbGbCtD
Nitric Oxide—CYP2B6—Dexamethasone—multiple sclerosis	0.0936	0.163	CbGbCtD
Nitric Oxide—CYP3A4—Methylprednisolone—multiple sclerosis	0.076	0.133	CbGbCtD
Nitric Oxide—CYP3A4—Triamcinolone—multiple sclerosis	0.0576	0.1	CbGbCtD
Nitric Oxide—CYP3A4—Mitoxantrone—multiple sclerosis	0.0555	0.0967	CbGbCtD
Nitric Oxide—CYP3A4—Betamethasone—multiple sclerosis	0.0494	0.0862	CbGbCtD
Nitric Oxide—CYP3A4—Prednisolone—multiple sclerosis	0.0488	0.085	CbGbCtD
Nitric Oxide—CYP3A4—Prednisone—multiple sclerosis	0.0461	0.0803	CbGbCtD
Nitric Oxide—CYP3A4—Dexamethasone—multiple sclerosis	0.0287	0.0501	CbGbCtD
Nitric Oxide—ALDH2—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—multiple sclerosis	0.0123	0.104	CbGpPWpGaD
Nitric Oxide—Haemorrhage intracranial—Mitoxantrone—multiple sclerosis	0.00908	0.0542	CcSEcCtD
Nitric Oxide—GUCY1A3—retina—multiple sclerosis	0.00774	0.0548	CbGeAlD
Nitric Oxide—GUCY1B3—retina—multiple sclerosis	0.00768	0.0544	CbGeAlD
Nitric Oxide—GUCY1A2—nervous system—multiple sclerosis	0.00667	0.0472	CbGeAlD
Nitric Oxide—ALDH2—retina—multiple sclerosis	0.00652	0.0461	CbGeAlD
Nitric Oxide—GUCY1A2—central nervous system—multiple sclerosis	0.00642	0.0455	CbGeAlD
Nitric Oxide—GUCY1A2—cerebellum—multiple sclerosis	0.00628	0.0444	CbGeAlD
Nitric Oxide—GUCY1A3—medulla oblongata—multiple sclerosis	0.00559	0.0396	CbGeAlD
Nitric Oxide—GUCY1B3—medulla oblongata—multiple sclerosis	0.00555	0.0393	CbGeAlD
Nitric Oxide—GUCY1A3—midbrain—multiple sclerosis	0.00511	0.0362	CbGeAlD
Nitric Oxide—Bradycardia—Fingolimod—multiple sclerosis	0.00511	0.0305	CcSEcCtD
Nitric Oxide—GUCY1A2—brain—multiple sclerosis	0.0051	0.0361	CbGeAlD
Nitric Oxide—GUCY1B3—midbrain—multiple sclerosis	0.00507	0.0359	CbGeAlD
Nitric Oxide—GUCY1A3—spinal cord—multiple sclerosis	0.00499	0.0353	CbGeAlD
Nitric Oxide—GUCY1B3—spinal cord—multiple sclerosis	0.00495	0.035	CbGeAlD
Nitric Oxide—ALDH2—medulla oblongata—multiple sclerosis	0.00471	0.0334	CbGeAlD
Nitric Oxide—Cardiac disorder—Fingolimod—multiple sclerosis	0.00466	0.0278	CcSEcCtD
Nitric Oxide—ALDH2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00456	0.0388	CbGpPWpGaD
Nitric Oxide—ALDH2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00456	0.0388	CbGpPWpGaD
Nitric Oxide—Angiopathy—Fingolimod—multiple sclerosis	0.00455	0.0272	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Fingolimod—multiple sclerosis	0.00452	0.027	CcSEcCtD
Nitric Oxide—ALDH2—midbrain—multiple sclerosis	0.00431	0.0305	CbGeAlD
Nitric Oxide—ALDH2—spinal cord—multiple sclerosis	0.0042	0.0297	CbGeAlD
Nitric Oxide—GUCY1A3—nervous system—multiple sclerosis	0.0042	0.0297	CbGeAlD
Nitric Oxide—GUCY1B3—nervous system—multiple sclerosis	0.00417	0.0295	CbGeAlD
Nitric Oxide—GUCY1A3—central nervous system—multiple sclerosis	0.00405	0.0286	CbGeAlD
Nitric Oxide—GUCY1B3—central nervous system—multiple sclerosis	0.00402	0.0284	CbGeAlD
Nitric Oxide—GUCY1A3—cerebellum—multiple sclerosis	0.00395	0.028	CbGeAlD
Nitric Oxide—GUCY1B3—cerebellum—multiple sclerosis	0.00392	0.0278	CbGeAlD
Nitric Oxide—ALDH2—nervous system—multiple sclerosis	0.00354	0.0251	CbGeAlD
Nitric Oxide—Nervous system disorder—Fingolimod—multiple sclerosis	0.0035	0.0209	CcSEcCtD
Nitric Oxide—ALDH2—central nervous system—multiple sclerosis	0.00341	0.0241	CbGeAlD
Nitric Oxide—ALDH2—cerebellum—multiple sclerosis	0.00333	0.0236	CbGeAlD
Nitric Oxide—Hypotension—Fingolimod—multiple sclerosis	0.00333	0.0199	CcSEcCtD
Nitric Oxide—GUCY1A3—Myometrial Relaxation and Contraction Pathways—RGS1—multiple sclerosis	0.00327	0.0278	CbGpPWpGaD
Nitric Oxide—GUCY1A3—brain—multiple sclerosis	0.00321	0.0227	CbGeAlD
Nitric Oxide—GUCY1B3—brain—multiple sclerosis	0.00319	0.0226	CbGeAlD
Nitric Oxide—Dyspnoea—Fingolimod—multiple sclerosis	0.00318	0.019	CcSEcCtD
Nitric Oxide—Haemoglobin—Cladribine—multiple sclerosis	0.00286	0.0171	CcSEcCtD
Nitric Oxide—Haemorrhage—Cladribine—multiple sclerosis	0.00284	0.017	CcSEcCtD
Nitric Oxide—ALDH2—brain—multiple sclerosis	0.00271	0.0192	CbGeAlD
Nitric Oxide—Gastrointestinal haemorrhage—Mitoxantrone—multiple sclerosis	0.0027	0.0161	CcSEcCtD
Nitric Oxide—Cardiac disorder—Cladribine—multiple sclerosis	0.00264	0.0158	CcSEcCtD
Nitric Oxide—Angiopathy—Cladribine—multiple sclerosis	0.00258	0.0154	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Cladribine—multiple sclerosis	0.00256	0.0153	CcSEcCtD
Nitric Oxide—ALDH2—Neuronal System—KCNA3—multiple sclerosis	0.00256	0.0217	CbGpPWpGaD
Nitric Oxide—ALDH2—Biological oxidations—CYP24A1—multiple sclerosis	0.00242	0.0206	CbGpPWpGaD
Nitric Oxide—ALDH2—Biological oxidations—CYP27B1—multiple sclerosis	0.00242	0.0206	CbGpPWpGaD
Nitric Oxide—Dizziness—Fingolimod—multiple sclerosis	0.00236	0.0141	CcSEcCtD
Nitric Oxide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00235	0.02	CbGpPWpGaD
Nitric Oxide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00235	0.02	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—SELPLG—multiple sclerosis	0.00235	0.02	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—MERTK—multiple sclerosis	0.00235	0.02	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—CD58—multiple sclerosis	0.00235	0.02	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—SELPLG—multiple sclerosis	0.00235	0.02	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—CD58—multiple sclerosis	0.00235	0.02	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—MERTK—multiple sclerosis	0.00235	0.02	CbGpPWpGaD
Nitric Oxide—Haemoglobin—Azathioprine—multiple sclerosis	0.00232	0.0139	CcSEcCtD
Nitric Oxide—Haemorrhage—Azathioprine—multiple sclerosis	0.00231	0.0138	CcSEcCtD
Nitric Oxide—Headache—Fingolimod—multiple sclerosis	0.00223	0.0133	CcSEcCtD
Nitric Oxide—Chest pain—Cladribine—multiple sclerosis	0.00211	0.0126	CcSEcCtD
Nitric Oxide—GUCY1A3—Hemostasis—CD58—multiple sclerosis	0.00209	0.0178	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—SELPLG—multiple sclerosis	0.00209	0.0178	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—MERTK—multiple sclerosis	0.00209	0.0178	CbGpPWpGaD
Nitric Oxide—Mediastinal disorder—Azathioprine—multiple sclerosis	0.00208	0.0124	CcSEcCtD
Nitric Oxide—Nervous system disorder—Cladribine—multiple sclerosis	0.00198	0.0118	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Cladribine—multiple sclerosis	0.00198	0.0118	CcSEcCtD
Nitric Oxide—Bradycardia—Mitoxantrone—multiple sclerosis	0.0019	0.0114	CcSEcCtD
Nitric Oxide—Hypotension—Cladribine—multiple sclerosis	0.00189	0.0113	CcSEcCtD
Nitric Oxide—Haemoglobin—Mitoxantrone—multiple sclerosis	0.00188	0.0112	CcSEcCtD
Nitric Oxide—Haemorrhage—Mitoxantrone—multiple sclerosis	0.00187	0.0112	CcSEcCtD
Nitric Oxide—Dyspnoea—Cladribine—multiple sclerosis	0.0018	0.0108	CcSEcCtD
Nitric Oxide—Gastrointestinal haemorrhage—Prednisone—multiple sclerosis	0.00161	0.00962	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Azathioprine—multiple sclerosis	0.00161	0.00961	CcSEcCtD
Nitric Oxide—CYP2B6—nervous system—multiple sclerosis	0.00159	0.0112	CbGeAlD
Nitric Oxide—Bradycardia—Prednisolone—multiple sclerosis	0.00156	0.00933	CcSEcCtD
Nitric Oxide—Haemoglobin—Prednisolone—multiple sclerosis	0.00154	0.00921	CcSEcCtD
Nitric Oxide—Hypotension—Azathioprine—multiple sclerosis	0.00154	0.00917	CcSEcCtD
Nitric Oxide—Haemorrhage—Prednisolone—multiple sclerosis	0.00153	0.00916	CcSEcCtD
Nitric Oxide—CYP2B6—central nervous system—multiple sclerosis	0.00153	0.0108	CbGeAlD
Nitric Oxide—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00149	0.0127	CbGpPWpGaD
Nitric Oxide—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00149	0.0127	CbGpPWpGaD
Nitric Oxide—CYP2B6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00148	0.0125	CbGpPWpGaD
Nitric Oxide—CYP2B6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00148	0.0125	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—PLEK—multiple sclerosis	0.00145	0.0123	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—PLEK—multiple sclerosis	0.00145	0.0123	CbGpPWpGaD
Nitric Oxide—Bradycardia—Triamcinolone—multiple sclerosis	0.00144	0.00858	CcSEcCtD
Nitric Oxide—Bradycardia—Methylprednisolone—multiple sclerosis	0.00143	0.00856	CcSEcCtD
Nitric Oxide—Haemoglobin—Triamcinolone—multiple sclerosis	0.00142	0.00847	CcSEcCtD
Nitric Oxide—Haemoglobin—Methylprednisolone—multiple sclerosis	0.00141	0.00845	CcSEcCtD
Nitric Oxide—Haemorrhage—Triamcinolone—multiple sclerosis	0.00141	0.00842	CcSEcCtD
Nitric Oxide—Convulsion—Mitoxantrone—multiple sclerosis	0.00141	0.00842	CcSEcCtD
Nitric Oxide—Haemorrhage—Methylprednisolone—multiple sclerosis	0.00141	0.00841	CcSEcCtD
Nitric Oxide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00139	0.0118	CbGpPWpGaD
Nitric Oxide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00139	0.0118	CbGpPWpGaD
Nitric Oxide—Chest pain—Mitoxantrone—multiple sclerosis	0.00139	0.00828	CcSEcCtD
Nitric Oxide—Dizziness—Cladribine—multiple sclerosis	0.00134	0.00798	CcSEcCtD
Nitric Oxide—Shock—Mitoxantrone—multiple sclerosis	0.00131	0.0078	CcSEcCtD
Nitric Oxide—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.00131	0.0078	CcSEcCtD
Nitric Oxide—Bradycardia—Betamethasone—multiple sclerosis	0.0013	0.00778	CcSEcCtD
Nitric Oxide—Bradycardia—Dexamethasone—multiple sclerosis	0.0013	0.00778	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.0013	0.00777	CcSEcCtD
Nitric Oxide—GUCY1A3—Hemostasis—PLEK—multiple sclerosis	0.00129	0.011	CbGpPWpGaD
Nitric Oxide—Haemoglobin—Dexamethasone—multiple sclerosis	0.00129	0.00768	CcSEcCtD
Nitric Oxide—Haemoglobin—Betamethasone—multiple sclerosis	0.00129	0.00768	CcSEcCtD
Nitric Oxide—Haemorrhage—Dexamethasone—multiple sclerosis	0.00128	0.00764	CcSEcCtD
Nitric Oxide—Haemorrhage—Betamethasone—multiple sclerosis	0.00128	0.00764	CcSEcCtD
Nitric Oxide—Angiopathy—Methylprednisolone—multiple sclerosis	0.00128	0.00763	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.00127	0.00758	CcSEcCtD
Nitric Oxide—Headache—Cladribine—multiple sclerosis	0.00127	0.00756	CcSEcCtD
Nitric Oxide—Hypotension—Mitoxantrone—multiple sclerosis	0.00124	0.00741	CcSEcCtD
Nitric Oxide—CYP2B6—brain—multiple sclerosis	0.00121	0.0086	CbGeAlD
Nitric Oxide—CYP2B6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00121	0.0103	CbGpPWpGaD
Nitric Oxide—CYP2B6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00121	0.0103	CbGpPWpGaD
Nitric Oxide—CYP3A4—nervous system—multiple sclerosis	0.0012	0.00849	CbGeAlD
Nitric Oxide—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00118	0.00707	CcSEcCtD
Nitric Oxide—Angiopathy—Dexamethasone—multiple sclerosis	0.00116	0.00694	CcSEcCtD
Nitric Oxide—Angiopathy—Betamethasone—multiple sclerosis	0.00116	0.00694	CcSEcCtD
Nitric Oxide—Convulsion—Prednisolone—multiple sclerosis	0.00116	0.00691	CcSEcCtD
Nitric Oxide—CYP3A4—central nervous system—multiple sclerosis	0.00116	0.00818	CbGeAlD
Nitric Oxide—Bradycardia—Prednisone—multiple sclerosis	0.00113	0.00678	CcSEcCtD
Nitric Oxide—Haemoglobin—Prednisone—multiple sclerosis	0.00112	0.00669	CcSEcCtD
Nitric Oxide—Haemorrhage—Prednisone—multiple sclerosis	0.00111	0.00666	CcSEcCtD
Nitric Oxide—Dizziness—Azathioprine—multiple sclerosis	0.00109	0.00649	CcSEcCtD
Nitric Oxide—Shock—Prednisolone—multiple sclerosis	0.00107	0.0064	CcSEcCtD
Nitric Oxide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00107	0.00909	CbGpPWpGaD
Nitric Oxide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00107	0.00909	CbGpPWpGaD
Nitric Oxide—Convulsion—Triamcinolone—multiple sclerosis	0.00106	0.00635	CcSEcCtD
Nitric Oxide—Convulsion—Methylprednisolone—multiple sclerosis	0.00106	0.00634	CcSEcCtD
Nitric Oxide—Headache—Azathioprine—multiple sclerosis	0.00103	0.00615	CcSEcCtD
Nitric Oxide—ALDH2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00103	0.00872	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—SELE—multiple sclerosis	0.00102	0.00869	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—SELE—multiple sclerosis	0.00102	0.00869	CbGpPWpGaD
Nitric Oxide—Angiopathy—Prednisone—multiple sclerosis	0.00101	0.00604	CcSEcCtD
Nitric Oxide—Shock—Triamcinolone—multiple sclerosis	0.000986	0.00589	CcSEcCtD
Nitric Oxide—Shock—Methylprednisolone—multiple sclerosis	0.000984	0.00588	CcSEcCtD
Nitric Oxide—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000981	0.00586	CcSEcCtD
Nitric Oxide—Convulsion—Dexamethasone—multiple sclerosis	0.000965	0.00577	CcSEcCtD
Nitric Oxide—Convulsion—Betamethasone—multiple sclerosis	0.000965	0.00577	CcSEcCtD
Nitric Oxide—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000947	0.00805	CbGpPWpGaD
Nitric Oxide—Haemoglobin—Methotrexate—multiple sclerosis	0.000936	0.00559	CcSEcCtD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000935	0.00795	CbGpPWpGaD
Nitric Oxide—Hypotension—Methylprednisolone—multiple sclerosis	0.000934	0.00558	CcSEcCtD
Nitric Oxide—Haemorrhage—Methotrexate—multiple sclerosis	0.000932	0.00556	CcSEcCtD
Nitric Oxide—GUCY1A3—Hemostasis—SELE—multiple sclerosis	0.000912	0.00774	CbGpPWpGaD
Nitric Oxide—Shock—Betamethasone—multiple sclerosis	0.000895	0.00534	CcSEcCtD
Nitric Oxide—Shock—Dexamethasone—multiple sclerosis	0.000895	0.00534	CcSEcCtD
Nitric Oxide—Dyspnoea—Triamcinolone—multiple sclerosis	0.000894	0.00534	CcSEcCtD
Nitric Oxide—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000892	0.00533	CcSEcCtD
Nitric Oxide—Nervous system disorder—Betamethasone—multiple sclerosis	0.000892	0.00533	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00089	0.00532	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00089	0.00532	CcSEcCtD
Nitric Oxide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00088	0.00748	CbGpPWpGaD
Nitric Oxide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00088	0.00748	CbGpPWpGaD
Nitric Oxide—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000869	0.00738	CbGpPWpGaD
Nitric Oxide—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000869	0.00738	CbGpPWpGaD
Nitric Oxide—Cardiac disorder—Methotrexate—multiple sclerosis	0.000865	0.00516	CcSEcCtD
Nitric Oxide—Hypotension—Betamethasone—multiple sclerosis	0.00085	0.00507	CcSEcCtD
Nitric Oxide—Hypotension—Dexamethasone—multiple sclerosis	0.00085	0.00507	CcSEcCtD
Nitric Oxide—Angiopathy—Methotrexate—multiple sclerosis	0.000845	0.00505	CcSEcCtD
Nitric Oxide—Convulsion—Prednisone—multiple sclerosis	0.000841	0.00502	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Methotrexate—multiple sclerosis	0.00084	0.00501	CcSEcCtD
Nitric Oxide—Headache—Mitoxantrone—multiple sclerosis	0.000832	0.00497	CcSEcCtD
Nitric Oxide—Shock—Prednisone—multiple sclerosis	0.000779	0.00465	CcSEcCtD
Nitric Oxide—Nervous system disorder—Prednisone—multiple sclerosis	0.000777	0.00464	CcSEcCtD
Nitric Oxide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00077	0.00654	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000755	0.00641	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—ITGA4—multiple sclerosis	0.000739	0.00628	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—ITGA4—multiple sclerosis	0.000739	0.00628	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—IFNB1—multiple sclerosis	0.000734	0.00623	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—IFNB1—multiple sclerosis	0.000734	0.00623	CbGpPWpGaD
Nitric Oxide—Dizziness—Prednisolone—multiple sclerosis	0.000721	0.0043	CcSEcCtD
Nitric Oxide—ALDH2—Neuronal System—BCHE—multiple sclerosis	0.000717	0.00609	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000714	0.00606	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000714	0.00606	CbGpPWpGaD
Nitric Oxide—Convulsion—Methotrexate—multiple sclerosis	0.000703	0.0042	CcSEcCtD
Nitric Oxide—Chest pain—Methotrexate—multiple sclerosis	0.00069	0.00412	CcSEcCtD
Nitric Oxide—Headache—Prednisolone—multiple sclerosis	0.000683	0.00408	CcSEcCtD
Nitric Oxide—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IL1B—multiple sclerosis	0.000683	0.0058	CbGpPWpGaD
Nitric Oxide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000679	0.00577	CbGpPWpGaD
Nitric Oxide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000679	0.00577	CbGpPWpGaD
Nitric Oxide—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00067	0.00569	CbGpPWpGaD
Nitric Oxide—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00067	0.00569	CbGpPWpGaD
Nitric Oxide—Dizziness—Triamcinolone—multiple sclerosis	0.000663	0.00396	CcSEcCtD
Nitric Oxide—Dizziness—Methylprednisolone—multiple sclerosis	0.000661	0.00395	CcSEcCtD
Nitric Oxide—GUCY1A3—Hemostasis—ITGA4—multiple sclerosis	0.000659	0.0056	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—IFNB1—multiple sclerosis	0.000654	0.00556	CbGpPWpGaD
Nitric Oxide—Nervous system disorder—Methotrexate—multiple sclerosis	0.000649	0.00388	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000648	0.00387	CcSEcCtD
Nitric Oxide—CYP2B6—Biological oxidations—CYP24A1—multiple sclerosis	0.000644	0.00547	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—CYP27B1—multiple sclerosis	0.000644	0.00547	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000635	0.00539	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000635	0.00539	CbGpPWpGaD
Nitric Oxide—Headache—Triamcinolone—multiple sclerosis	0.000628	0.00375	CcSEcCtD
Nitric Oxide—Headache—Methylprednisolone—multiple sclerosis	0.000626	0.00374	CcSEcCtD
Nitric Oxide—Hypotension—Methotrexate—multiple sclerosis	0.000618	0.00369	CcSEcCtD
Nitric Oxide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.00061	0.00518	CbGpPWpGaD
Nitric Oxide—Dizziness—Betamethasone—multiple sclerosis	0.000601	0.00359	CcSEcCtD
Nitric Oxide—Dizziness—Dexamethasone—multiple sclerosis	0.000601	0.00359	CcSEcCtD
Nitric Oxide—Dyspnoea—Methotrexate—multiple sclerosis	0.00059	0.00352	CcSEcCtD
Nitric Oxide—ALDH2—Metabolism—SRM—multiple sclerosis	0.000589	0.005	CbGpPWpGaD
Nitric Oxide—Headache—Betamethasone—multiple sclerosis	0.00057	0.0034	CcSEcCtD
Nitric Oxide—Headache—Dexamethasone—multiple sclerosis	0.00057	0.0034	CcSEcCtD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000551	0.00468	CbGpPWpGaD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000551	0.00468	CbGpPWpGaD
Nitric Oxide—ALDH2—Biological oxidations—POMC—multiple sclerosis	0.000545	0.00463	CbGpPWpGaD
Nitric Oxide—Dizziness—Prednisone—multiple sclerosis	0.000524	0.00313	CcSEcCtD
Nitric Oxide—GUCY1A2—Hemostasis—IL2RA—multiple sclerosis	0.000505	0.00429	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—IL2RA—multiple sclerosis	0.000505	0.00429	CbGpPWpGaD
Nitric Oxide—Headache—Prednisone—multiple sclerosis	0.000496	0.00296	CcSEcCtD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000474	0.00402	CbGpPWpGaD
Nitric Oxide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000454	0.00385	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—IL2RA—multiple sclerosis	0.00045	0.00382	CbGpPWpGaD
Nitric Oxide—Dizziness—Methotrexate—multiple sclerosis	0.000438	0.00261	CcSEcCtD
Nitric Oxide—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000419	0.00356	CbGpPWpGaD
Nitric Oxide—Headache—Methotrexate—multiple sclerosis	0.000415	0.00248	CcSEcCtD
Nitric Oxide—ALDH2—Metabolism—CYP27B1—multiple sclerosis	0.000415	0.00352	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CYP24A1—multiple sclerosis	0.000415	0.00352	CbGpPWpGaD
Nitric Oxide—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000412	0.0035	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IL6—multiple sclerosis	0.0004	0.0034	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GPC5—multiple sclerosis	0.000379	0.00322	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000379	0.00322	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000379	0.00322	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000374	0.00318	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000374	0.00318	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—ALB—multiple sclerosis	0.000365	0.0031	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—ALB—multiple sclerosis	0.000365	0.0031	CbGpPWpGaD
Nitric Oxide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00035	0.00297	CbGpPWpGaD
Nitric Oxide—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000336	0.00286	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—ALB—multiple sclerosis	0.000325	0.00276	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—RRM1—multiple sclerosis	0.000314	0.00267	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—IL2—multiple sclerosis	0.000296	0.00252	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—IL2—multiple sclerosis	0.000296	0.00252	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000293	0.00248	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000293	0.00248	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000288	0.00245	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000288	0.00245	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000273	0.00232	CbGpPWpGaD
Nitric Oxide—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000273	0.00232	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—IL2—multiple sclerosis	0.000264	0.00224	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—TGFB1—multiple sclerosis	0.000231	0.00196	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—TGFB1—multiple sclerosis	0.000231	0.00196	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—MAPK1—multiple sclerosis	0.000227	0.00192	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—MAPK1—multiple sclerosis	0.000227	0.00192	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—MAPK1—multiple sclerosis	0.000209	0.00178	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—TGFB1—multiple sclerosis	0.000206	0.00175	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000204	0.00173	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—MAPK1—multiple sclerosis	0.000202	0.00171	CbGpPWpGaD
Nitric Oxide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000198	0.00168	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.000182	0.00154	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000181	0.00154	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—BCHE—multiple sclerosis	0.00018	0.00153	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000161	0.00136	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—SRM—multiple sclerosis	0.000156	0.00133	CbGpPWpGaD
Nitric Oxide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000153	0.0013	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000146	0.00124	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000146	0.00124	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—POMC—multiple sclerosis	0.000145	0.00123	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000142	0.0012	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000141	0.0012	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.000138	0.00118	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.000132	0.00112	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.000132	0.00112	CbGpPWpGaD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000124	0.00105	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	0.00011	0.000935	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	0.00011	0.000935	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—APOE—multiple sclerosis	0.000109	0.000922	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GPC5—multiple sclerosis	0.000101	0.000855	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—POMC—multiple sclerosis	9.33e-05	0.000792	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—SRM—multiple sclerosis	9.2e-05	0.000781	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—POMC—multiple sclerosis	8.53e-05	0.000724	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—ALB—multiple sclerosis	8.5e-05	0.000722	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—RRM1—multiple sclerosis	8.34e-05	0.000709	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—SRM—multiple sclerosis	7.1e-05	0.000603	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—POMC—multiple sclerosis	6.58e-05	0.000559	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	6.48e-05	0.000551	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	6.48e-05	0.000551	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.34e-05	0.000538	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GPC5—multiple sclerosis	5.93e-05	0.000504	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	5e-05	0.000425	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	5e-05	0.000425	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—RRM1—multiple sclerosis	4.91e-05	0.000417	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—BCHE—multiple sclerosis	4.79e-05	0.000407	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GPC5—multiple sclerosis	4.58e-05	0.000389	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.81e-05	0.000324	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—RRM1—multiple sclerosis	3.79e-05	0.000322	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.27e-05	0.000278	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.98e-05	0.000254	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—APOE—multiple sclerosis	2.88e-05	0.000245	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—BCHE—multiple sclerosis	2.82e-05	0.00024	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—POMC—multiple sclerosis	2.48e-05	0.00021	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ALB—multiple sclerosis	2.26e-05	0.000192	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—BCHE—multiple sclerosis	2.18e-05	0.000185	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—APOE—multiple sclerosis	1.7e-05	0.000144	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—POMC—multiple sclerosis	1.46e-05	0.000124	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ALB—multiple sclerosis	1.33e-05	0.000113	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—APOE—multiple sclerosis	1.31e-05	0.000111	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—POMC—multiple sclerosis	1.13e-05	9.56e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ALB—multiple sclerosis	1.03e-05	8.71e-05	CbGpPWpGaD
